Je was op zoek naar: farmakoteraapia (Estisch - Engels)

farmakoloogia ja farmakoteraapia
pharmacology and pharmacotherapy

pikaajaline asendusravi ei ole opioidisõltuvuse farmakoteraapia ainus eesmärk.
long-term drug substitution is not the only purpose of opioid pharmacotherapy.

mõned raviarstid toetavad samaaegset käitumusliku pssühhoteraapia rakendamist patsientidel, kellele on farmakoteraapia hästi mõjunud.
some clinicians advocate concomitant behavioural psychotherapy for patients who have done well on pharmacotherapy.

ravimitega varustamise tagav apteek kindlustab ka haigla personali pideva nõustamise, et saavutada tõhus ja soodne farmakoteraapia;
the supplying pharmacy ensures that it provides hospital staff with advice on a continuous basis with a view to effective and economic pharmacotherapy;

5. ravimitega varustamise tagav apteek kindlustab ka haigla personali pideva nõustamise, et saavutada tõhus ja soodne farmakoteraapia;
5. the supplying pharmacy ensures that it provides hospital staff with advice on a continuous basis with a view to effective and economical pharmacotherapy;

kuid oma põhjalikus ülevaates farmakoteraapia kasutamisest psühhostimulantide tarbijatel jõuavad shearer ja gowing (2004) järeldusele, et stimulantide tarbijate puhul
however, in their comprehensive review of the use of pharmacotherapies for psychostimulant users, shearer and gowing (2004) conclude that substitution therapy, which is successful in the case of opioid and nicotine dependence and has the potential for attracting and retaining users in treatment, has not yet been adequately tested in stimulant

patsiendi ravivastust ja farmakoteraapia jätkamise vajadust tuleb hinnata regulaarselt (näiteks kord kuus) (vt lõik 5.1).
the patient’s response to treatment and the need for continued pharmacotherapy should be evaluated on a regular (for example, monthly) basis (see section 5.1).

haiglaapteegi juhataja või tema poolt volitatud proviisor pakub haigla arstidele ravimialast teavitust ja nõustamist eeskätt selleks, et tagada tõhus ja soodne farmakoteraapia; sama kehtib ambulatoorse ravi puhul.
the manager of the hospital pharmacy or a pharmacist authorised by him must give information and advice to the medical staff of the hospital on the medicinal products, in particular for the purposes of effective and economical pharmacotherapy; the same applies in relation to out-patient treatment.

kahjustuste, haigusseisundite, protseduuride ja/või farmakoteraapia (nagu mspvr-d, trombolüütikumid, ssti-d ja snti-d, vt lõik 4.5) olemasolu, mis suurendab oluliselt suuremate verejooksude ohtu, vajab hoolikat kasu ja riski hindamist.
the presence of lesions, conditions, procedures and/or pharmacological treatment (such as nsaids, antiplatelets, ssris and snris, see section 4.5), which signficantly increase the risk of major bleeding requires a careful benefit-risk assessment.